Tiny implant could replace weekly Weight-Loss shots
Disease control
Not yet recruiting
This early-stage study is testing a small, under-the-skin implant that slowly releases the weight-management medication semaglutide. It will compare the safety and drug levels of this single 4-week implant against four weekly injections of the same drug. The goal is to see if the…
Phase: PHASE1 • Sponsor: Vivani Medical, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC